Dow Jones

38,686.32

1.51%

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

OYST

Oyster Point Pharma (OYST)

Oyster Point Pharma Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OYST

1 2 3 4 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
14/02/2023	15:34	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:OYST	Oyster Point Pharma Inc
13/01/2023	16:11	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:OYST	Oyster Point Pharma Inc
13/01/2023	16:06	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:OYST	Oyster Point Pharma Inc
06/01/2023	05:04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:OYST	Oyster Point Pharma Inc
05/01/2023	15:33	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:OYST	Oyster Point Pharma Inc
05/01/2023	15:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OYST	Oyster Point Pharma Inc
03/01/2023	08:53	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:OYST	Oyster Point Pharma Inc
03/01/2023	08:26	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:OYST	Oyster Point Pharma Inc
03/01/2023	08:19	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:OYST	Oyster Point Pharma Inc
03/01/2023	08:07	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:OYST	Oyster Point Pharma Inc
23/12/2022	05:31	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:OYST	Oyster Point Pharma Inc
22/12/2022	16:16	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:OYST	Oyster Point Pharma Inc
02/12/2022	07:00	GlobeNewswire Inc.	Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:OYST	Oyster Point Pharma Inc
01/12/2022	05:12	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:OYST	Oyster Point Pharma Inc
16/11/2022	15:25	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:OYST	Oyster Point Pharma Inc
14/11/2022	07:10	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:OYST	Oyster Point Pharma Inc
10/11/2022	15:15	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:OYST	Oyster Point Pharma Inc
10/11/2022	15:11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OYST	Oyster Point Pharma Inc
10/11/2022	15:05	GlobeNewswire Inc.	Oyster Point Pharma Reports Third Quarter 2022 Financial Results and Recent Business Highlights	NASDAQ:OYST	Oyster Point Pharma Inc
07/11/2022	07:00	GlobeNewswire Inc.	Oyster Point Pharma, a Leading Ophthalmology-Focused Biopharmaceutical Company, to be Acquired by Viatris	NASDAQ:OYST	Oyster Point Pharma Inc
02/11/2022	15:02	GlobeNewswire Inc.	Oyster Point Pharma To Report Third Quarter 2022 Financial Results On November 10, 2022	NASDAQ:OYST	Oyster Point Pharma Inc
27/09/2022	07:00	GlobeNewswire Inc.	Oyster Point Pharma to Present New Scientific Analyses at World Cornea Congress VIII	NASDAQ:OYST	Oyster Point Pharma Inc
07/09/2022	16:36	GlobeNewswire Inc.	Oyster Point Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:OYST	Oyster Point Pharma Inc
25/08/2022	07:00	GlobeNewswire Inc.	Oyster Point Pharma to Present Analyses at the Women in Ophthalmology Summer Symposium	NASDAQ:OYST	Oyster Point Pharma Inc
17/08/2022	07:00	GlobeNewswire Inc.	Oyster Point Pharma Announces TYRVAYA® To Be Covered By the Largest Medicare Pharmacy Benefit Manager	NASDAQ:OYST	Oyster Point Pharma Inc
15/08/2022	07:00	GlobeNewswire Inc.	Oyster Point Pharma To Attend H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference on August 17, 2022	NASDAQ:OYST	Oyster Point Pharma Inc
11/08/2022	15:01	GlobeNewswire Inc.	Oyster Point Pharma Reports Second Quarter 2022 Financial Results and Recent Business Highlights	NASDAQ:OYST	Oyster Point Pharma Inc
08/08/2022	15:03	GlobeNewswire Inc.	Oyster Point Pharma To Report Second Quarter 2022 Financial Results On August 11, 2022	NASDAQ:OYST	Oyster Point Pharma Inc
27/07/2022	06:00	GlobeNewswire Inc.	Oyster Point Pharma Announces Expanded Patient Access to TYRVAYA®	NASDAQ:OYST	Oyster Point Pharma Inc
18/07/2022	05:17	TipRanks	H.C. Wainwright Thinks Oyster Point Pharma’s Stock is Going to Recover	NASDAQ:OYST	Oyster Point Pharma Inc